University of South Carolina

Scholar Commons
Publications

Artificial Intelligence Institute

6-6-2022

Knowledge-Driven Drug-Use NamedEntity Recognition with
Distant Supervision
Goonmeet Bajaj
Ohio State University - Main Campus

Ugur Kursuncu
Georgia State University

Manas Gaur
University of South Carolina - Columbia

Usha Lokala
University of South Carolina - Columbia

Ayaz Hyder
Ohio State University - Main Campus

See next page for additional authors

Follow this and additional works at: https://scholarcommons.sc.edu/aii_fac_pub
Part of the Computer Engineering Commons, and the Electrical and Computer Engineering Commons

Publication Info
Published in Studies in Health Technology and Informatics, Volume 290, 2022, pages 140-144.
© 2022 International Medical Informatics Association (IMIA) and IOS Press. This article is published
online with Open Access by IOS Press and distributed under the terms of the Creative Commons
Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).

This Paper is brought to you by the Artificial Intelligence Institute at Scholar Commons. It has been accepted for
inclusion in Publications by an authorized administrator of Scholar Commons. For more information, please
contact digres@mailbox.sc.edu.

Author(s)
Goonmeet Bajaj, Ugur Kursuncu, Manas Gaur, Usha Lokala, Ayaz Hyder, Srinivasan Parthasarathy, and
Amit Sheth

This paper is available at Scholar Commons: https://scholarcommons.sc.edu/aii_fac_pub/545

140

MEDINFO 2021: One World, One Health – Global Partnership for Digital Innovation
P. Otero et al. (Eds.)
© 2022 International Medical Informatics Association (IMIA) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI220048

Knowledge-Driven Drug-Use NamedEntity Recognition with Distant Supervision
Goonmeet Bajaja, Ugur Kursuncub, Manas Gaurb, Usha Lokalab, Ayaz Hyderc, Srinivasan Parthasarathya and Amit Shethb
b

a
Department of Computer Science and Engineering, The Ohio State University, Columbus, Ohio, USA
Division of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, Ohio, USA
c
AI Institute, University of South Carolina, Columbia, City Two, South Carolina, USA

Abstract
As Named Entity Recognition (NER) has been essential in
identifying critical elements of unstructured content, generic
NER tools remain limited in recognizing entities specific to a
domain, such as drug use and public health. For such highimpact areas, accurately capturing relevant entities at a more
granular level is critical, as this information influences realworld processes. On the other hand, training NER models for a
specific domain without handcrafted features requires an
extensive amount of labeled data, which is expensive in human
effort and time. In this study, we employ distant supervision
utilizing a domain-specific ontology to reduce the need for
human labor and train models incorporating domain-specific
(e.g., drug use) external knowledge to recognize domain
specific entities. We capture entities related the drug use and
their trends in government epidemiology reports, with an
improvement of 8% in F1-score.
Keywords:
Natural Language Processing, Deep Learning, Information
Storage and Retrieval

Introduction
Named Entity Recognition (NER) is a fundamental Natural
Language Processing (NLP) task used to detect important entities mentioned in text and classify them using predefined types.
NER has critical utility for a variety of downstream tasks in
pipelines, including knowledge extraction, targeted sentiment
analysis [1], question answering [2], information retrieval [2],
and dialogue systems [3]. Existing (i.e., off-the-shelf) NER approaches and tools often cover an inadequate set of named entities, which can be incomplete for a specific domain. Many offthe-shelf NER tools tag a limited number of named entities (up
to 18) that are often not domain-specific. The lack of domainspecific NER models becomes a significant bottleneck as it can
lead to potentially inaccurate recognition and/or inadequate
coverage of domain-specific information for high-impact domains, such as healthcare and public health. It further magnifies
such impact when such models influence important decisionmaking processes, e.g., policy-making.
Historically, NER models have been trained using sequential
models (e.g., Hidden Markov Model (HMM)) [4] and Conditional Random Fields (CRFs) using handcrafted features [5].
However, designing handcrafted features is a non-trivial task
and requires significant time, effort, and knowledge of domain
1

https://spacy.io

experts. More recently, neural networks have become state-ofthe-art models for NER achieving higher performance [6, 7].
However, these models still require an extensive collection of
labeled documents which is time-consuming, tedious, and expensive to acquire. Recent approaches employ distant supervision to automatically create labeled data [9, 10, 8] by utilizing
knowledge bases (e.g., Wikipedia, YAGO, MeSH) to reduce
this need for extensive human expert involvement.
Shang et al. developed a framework to handle noisy distant labels applied using a dictionary [8]. They modify a fuzzy CRF
layer to manage tokens with multiple possible labels and use a
neural model, AutoNER, with a Tie or Break scheme to determine if adjacent tokens belong to the same entity type. [9] develop a weekly supervised approach, Trove, using medical ontologies for entity classification. Trove requires a user-defined
mapping of an ontology’s class taxonomy to entity classes, a set
of label sources (for weak supervision), regular expressions,
and a collection of unlabeled documents (used to build a training set). Similarly, Laing et al. develop a two-stage training algorithm, BOND, that uses pre-trained language models to improve open-domain NER [15]. During the first stage, they adapt
a pre-trained language model with distant labels. In the second
stage, they apply a self-training approach and drop the distant
labels using handcrafted rules and knowledge bases.
In this work, we train a NER model for drug trend reports using
the Drug Abuse Ontology (DAO) [11, 12] and spaCy1 (token2vec) that can tag domain-specific (e.g., drug use) and generic named entities. As our approach does not require handcrafted rules, we use the ontology to semantically annotate the
data via distant supervision. We employ both generic entities
through spaCy and domain-specific entities identified from
DAO by our collaborator domain expert. Then, we use the semantically annotated data to fine-tune transformer-based language models that have achieved state-of-the-art results on
NER tasks. We find that this framework allows us to extract
both domain-specific and generic named entities with high precision, recall, and F1-score without the need for handcrafted
regular expressions and rules.
In this study, we make the following contributions utilizing an
ontology: i) we automatically label a large amount of data using
distant supervision, which is critical for the state-of-the-art deep
learning language models and ii) we develop a domain-specific
NER model for epidemiology reports that tags both generic
named entities and domain-specific entities. We are happy to
share the annotated data and trained models.
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Methods

Final Experimental Datasets: We use three datasets to benchmark the performance of our model:
1. OntoNotes (ON) – OntoNotes 5.0 training and
validation splits with 18 NER types

Datasets
Drug Abuse Ontology: An ontology represents knowledge of
a particular domain as a set of concepts and relationships among
the concepts. Ontologies describe a domain and are used to reason about the entities within that domain. Precisely, DAO consists of 315 classes, 31 relationships, and 814 instances of the
classes [12]. DAO formalizes concepts and entities that are relevant to addiction and mental health. The ontology includes
representation of drugs, including slang and brand names,
chemical designation, dosage and unit, purity, the form of preparation. We direct interested readers to [11, 12] to learn more
about DAO.
Drug Trends Reports from the Ohio Substance Abuse Monitoring (OSAM) Network: The OSAM Network2 consists of
epidemiologists from eight regions of Ohio. The epidemiologists conduct focus groups and individual qualitative interviews
with active and recovering drug users and community professionals (treatment providers, law enforcement officials, etc.) to
produce epidemiological descriptions of local substance abuse
trends. Additionally, the epidemiologists report qualitative
findings from coroner’s reports and crime laboratory data, provide information related to substance abuse trends from mass
media sources. These reports offer policy-makers real-time accurate epidemiological information to plan prevention and intervention strategies. Such information describes substance
abuse trends across the state, focusing on drug availability,
prices, quality, and abuse patterns. The OSAM network publishes the reports on a semiannual basis in January and June of
each year.
In public health settings, the OSAM drug trend reports serve
two primary purposes: surveillance and planning. For surveillance, the primary data points of interest are: i) date and time,
ii) the drug types, quantities, amounts, units and percent change
in quantities of a drug in a community, iii) health conditions
affected in the population, and iv) organizations involved in
drug-related activities. It is critical to identify a combination of
named- and domain-specific entities to capture these data
points. For planning purposes, such as making policy changes
based on these reports or planning an intervention in a specific
region, recognizing similar entities would be of significant interest to public health departments. These entities would include: i) drug type, substance use, and changes in route of administration, ii) information on ethnic groups, iii) health conditions, individual and societal, and economic factors, and iv) information on organizations. We obtained 102 OSAM Drug
Trend reports from January 2014 to January 2020, covering the
eight Ohio regions. We use the 2020 reports as our validation
dataset.
OntoNotes 5.0 datasets: OntoNotes 5.0 dataset [13] contains
18 generic entity types. This dataset provides labeled corpus
from many genres (news, conversational telephone speech,
weblogs, newsgroups, broadcast, talk shows, etc.) in three languages (English, Chinese, and Arabic) with structural information (syntax and predicate-argument structure) and shallow
semantics (word sense linked to an ontology and co-reference).
We used the OntoNotes 5.0 dataset to provide distant supervision for generic entity types because of the diversity of information and a higher number of entity types when compared to
other benchmarking NER datasets.

2 https://mha.ohio.gov/Researchers-and-Media/Workgroups-and-Networks/Ohio-Substance-Abuse-Monitoring-Network
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2. OntoNotes + DrugTrends (ON + DT) – For this
dataset, we combine the training splits from the
OntoNotes 5.0 and the OSAM Drug Trend Reports
from 2014 to 2019. However, we only use the 18
generic NER labels mentioned above. We do not add
the labels from DAO and do not modify the validation
set from the OntoNotes 5.0 dataset.
3. OntoNotes + DrugTrends + DAO (ON + DT +
DAO) – For this dataset, we combine the training splits
from the OntoNotes 5.0 and the OSAM Drug Trend
Reports from 2014 to 2019. We combine the
OntoNotes 5.0 validation set with the OSAM Drug
Trend Reports from 2020 to create a validation set.
Here, we use both the 18 generic NER labels and the
domain-specific labels selected from DAO.
Semantic Data Annotation with Distant Supervision: The
OSAM Drug Trend reports contain generic named entities (e.g.,
DATE, LOCATION, GPE) and domain-specific entities such
as DRUG and HEALTH-CONDITIONS. Therefore, we employ two different approaches to label our training data. We label our dataset with entity types using the Inside, Outside, Beginning (IBO/BIO) scheme. The IBO format is commonly used
to label entities in a chunking task in computational linguistics
such as NER. Specifically, we recognize domain-specific
named entities in the drug trends reports by mapping words in
the text to the instances in DAO and label them with their respective entity types.
Generic Entity Types: We use the en_core_web_lg spaCy (token2vec) model3 to label OSAM reports with one of the following 18 entity types: CARDINAL, DATE, EVENT, FAC, GPE,
LANGUAGE, LAW, LOC, MONEY, NORP, ORDINAL,
ORG, PERCENT, PERSON, PRODUCT, QUANTITY, TIME,
and WORK OF ART (WoA). The en core_web_lg spaCy
model is trained using the OntoNotes 5.0 dataset [13]. We experimented with fine-tuning BERT [20] using the OntoNotes
5.0 dataset [13] but found the spaCy model outperforming
BERT on the OntoNotes 5.0 validation dataset.

Figure 1 - Framework Overview
Domain-Specific Entity Types: To provide distant supervision for entities in the drug trends reports, we utilize DAO that
contains 315 classes. Instead of using all classes as entity types,
our collaborator, a public health expert, identified and validated
the essential entity types for this study: TIME, UNIT, DRUG,
HEALTH CONDITIONS, INDIVIDUAL RELATED,
PYSCHOSTIMULANTS,
NETWORK
RELATED,
3

https://spacy.io/models/en
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SOCIETY, SOURCES, ROUTE OF ADMINISTRATION,
SUBSTANCE RELATED, and UNIT. Our framework allows
domain experts to select the entity types deemed as most appropriate for their respective domains.
Modeling
We use our labeled dataset (generated using semantic data annotation with distant supervision) to train state-of-the-art transformer-based language models for the NER task, such as BERT
[19] and BOND [15]. We also use these techniques to compare
the performance of NER models with and without using domain-specific corpus (e.g., drug trends reports) and DAO. In
this section, we describe the baseline approaches and our approaches for the domain-specific NER task. Our framework is
outlined in Figure 1.
Baselines: We used the tok2vec model from spaCy,
en_core_web_lg, as our very first baseline with results that
were reasonably satisfactory (See Section 5.1). In addition, we
use transfer learning for BERT [20] by fine-tuning using only
the OntoNotes 5.0 dataset to compare the performance for generic entity types. We present the results for tok2vec and the
fine-tuned BERT model in the Results Section (see Table 1).
Additional experimental results are provided within the supplementary material.
BOND: We trained BOND [15] using the three datasets described above. In addition, we replaced the RoBERTa model
[22] with BERT and BioClinicalBERT [21] during Stage I of
BOND, while we did not see a significant improvement in performance using Stage II (self-training). Therefore, we did not
change the underlying transformer model for State II.

Results

Due to the space restrictions, we only provide three sets of experimental results for: i) OntoNotes (ON) with token2vec, ii)
OntoNotes + DrugTrends + DAO (ON + DT + DAO) with BioClinicalBERT, and ii) OntoNotes + DrugTrends + DAO (ON
+ DT + DAO) with BOND Stage I with RoBERTA.
Findings from our other experiments (not reported): We
compare the performance of BERT and token2vec (via spaCy)
on the ON dataset. We find that token2vec provides better performance over BERT. Among token2vec, BERT, and BOND
(Stage I and Stage II models) trained over the ON + DT dataset,
BOND with RoBERTA outperforms the others. The results
from the fine-tuned BioClinicalBERT models are comparable
to that of BOND’s Stage I training with BioClinicalBERT for
ON + DT + DAO dataset.
Findings from Table 1: We observe that BioClinicalBERT
and BOND (Stage I - RoBERTa) performs better than BERT as
expected, since the models were pre-trained on medical corpora
and fine-tuned with our ON + DT + DAO dataset. On the other
hand, we observe that BOND - Stage I with RoBERTa outperforms BioClinicalBERT in F1-score. However, we note that the
performance gain of BOND with RoBERTa is attributed to generic NER labels, as BioClinicalBERT outperforms for domain-specific entity labels.
Overall, the results indicate that adding Drug Trends reports
during the fine-tuning process improves the BERT models' performance (BERT model, BOND with BERT, BOND with RoBERTa) to extract generic NER labels in the OntoNotes dataset.
The fine-tuned BioClinicalBert has higher performance for
DAO labels when compared to BOND with BioClinicalBert. In
our evaluation, we omit results from experiments with poor results, and they are as follows: i) for ON dataset and BOND
(Stage I and Stage II models) ii) for ON+DT dataset and BOND
Stage II model (Self-Training).

We evaluate the aforementioned models using precision, recall,
F1 score, and the macro and weighted averages. Table 1 presents the results from our experiments.
Table 1 - Experimental Results

NAMED ENTITY
CARDINAL
DATE
EVENT
FAC
GPE
LANGUAGE
LAW
LOC
MONEY
NORP
ORDINAL
ORG
PERCENT
PERSON
PRODUCT
QUANTITY
TIME
WoA
DRUG
ETH_GRP

P
0.70
0.78
0.58
0.43
0.82
0.76
0.48
0.58
0.91
0.81
0.66
0.74
0.90
0.67
0.32
0.65
0.62
0.28
-

token2vec
(ON)
R
F
0.89 0.77
0.88 0.83
0.37 0.45
0.45 0.43
0.91 0.87
0.67 0.71
0.51 0.50
0.60 0.59
0.92 0.91
0.93 0.87
0.84 0.64
0.87 0.80
0.89 0.89
0.93 0.78
0.15 0.2
0.64 0.64
0.73 0.67
0.19 0.22
-

BioClinical-BERT
(ON + DT + DAO)
P
F
R
0.87 0.92 0.89
0.87 0.90 0.89
0.60 0.51 0.55
0.42 0.52 0.46
0.91 0.93 0.92
0.83 0.69 0.75
0.48 0.59 0.53
0.69 0.69 0.69
0.91 0.91 0.91
0.87 0.90 0.89
0.75 0.82 0.79
0.85 0.88 0.87
0.91 0.90 0.91
0.89 0.93 0.91
0.52 0.48 0.50
0.82 0.84 0.83
0.73 0.81 0.77
0.41 0.46 0.43
1.00 1.00 1.00
0.99 1.00 1.00

BOND-RoBERTA
(ON + DT + DAO)
P
F
R
0.88 0.93 0.90
0.88 0.90 0.98
0.73 0.57 0.64
0.50 0.63 0.56
0.92 0.94 0.93
0.73 0.63 0.68
0.44 0.51 0.47
0.71 0.75 0.73
0.92 0.93 0.93
0.87 0.89 0.88
0.76 0.84 0.80
0.87 0.89 0.88
0.92 0.90 0.91
0.91 0.94 0.93
0.62 0.46 0.53
0.81 0.86 0.83
0.75 0.82 0.78
0.57 0.52 0.55
1.00 1.00 1.00
1.00 1.00 1.00
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HLT_COND
INDIV_REL
NET_REL
PSYSTIMU.
RoA
SOCIETY
SOURCES
SPAT_REL
SUB_REL
UNIT
Macro Avg
Weighted Avg

0.65
0.75

0.68
0.86

0.66
0.80

0.97
0.97
0.98
1.00
1.00
0.99
0.99
0.99
0.97
0.99
0.84
0.90

0.99
0.99
0.99
1.00
1.00
0.99
0.99
0.99
1.00
1.00
0.86
0.92

0.98
0.98
0.98
1.00
1.00
0.99
0.99
0.99
0.98
1.00
0.85
0.91

0.97
0.97
0.99
1.00
0.99
1.00
0.99
0.98
0.96
0.96
0.85
0.91

0.99
1.00
1.00
1.00
1.00
1.00
0.99
1.00
1.00
1.00
0.86
0.93
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0.98
0.98
0.99
1.00
1.00
1.00
0.99
0.99
0.98
0.98
0.86
0.92

Figure 2 - spaCy (token2vec) Tagged Entities

Discussion
The pipeline in our study indicated that most entities based on
the Drug Trends reports and DAO were essential for their relevance to public health practice. Also, the weighted average
across the different models indicated that BioClinicalBERT and
BOND - Baseline RoBERTa were adequate for applying our
pipeline for public health practice in terms of opioid addiction
surveillance and planning/policy purposes. Figures 2 and 3 present a sampled sentence tagged with named entities using
spaCy (token2vec) and BioClinicalBERT, respectively. From
these images, we can see that BioClinicalBERT captures more
domain-specific entities. The overall performance of different
algorithms on identifying named and domain-specific entities
showed the utility of our pipeline for public health practice.
Public health departments may use the information generated
through this pipeline to quickly identify emerging trends across
their region or compare trends across regions given a specific
drug type or health conditions. Another potential use for a
statewide agency (e.g., Ohio Department of Health or Ohio Department of Medicaid, or Ohio Department of Public Safety)
may be to query multiple reports across Ohio based on a given
drug type, route of administration, and health conditions. The
ability to quickly glean the information from drug trend reports
in a standardized manner when the underlying structure of drug
trend reports is not available in a standardized format is a significant step forward for public health departments. Our team
can automate the pipeline proposed in this study and provide
organized data to public health departments in an analysisready dataset. Such a dataset may be integrated into existing
opioid surveillance systems and complement these existing systems with a rich source of quantitative data extracted from a
mainly qualitative data source (i.e., drug trend reports) quickly
and efficiently. Future work based on this pipeline will attempt
an integration in collaboration with local health departments in
Ohio that are building an integrated opioid surveillance system.

Figure 3 - BioClinicalBERT Tagged Entities

Conclusions
In this work, we utilized deep language models along with Drug
Abuse Ontology (DAO) for named entity recognition task in the
public health domain. We demonstrate that semantically-annotated data with distant supervision boosts the utility of the stateof-the-art language models, which requires large datasets, for
domain-specific tasks. Specifically, we found that this approach
allows us to extract both domain-specific and generic named
entities with high precision, recall and F1-score without spending extreme resources and time to label training data.
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